跳至主要内容
临床试验/NCT01437826
NCT01437826终止3 期

Evaluation of the Efficacy of a Combination of Micronutrients (Vitamin A, C, E, Selenium and Zinc) in Reducing the Incidence of Colorectal Metachronous Adenomas. A Double Blind, Phase III, Randomized, Placebo-controlled Trial

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy1 个研究点 分布在 1 个国家目标入组 411 人开始时间: 2011年9月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
入组人数
411
试验地点
1
主要终点
occurrence of metachronous adenomas or cancer detected during endoscopic follow up examinations

研究概览

简要总结

The trial was aimed at evaluating the efficacy of a multiagent antioxidant compound (vitamin A, C, E, selenium and zinc) in reducing the incidence of metachronous adenomas of the large bowel after endoscopic polypectomy. This is a randomized study: a 50% reduction in the incidence of metachronous adenomas was expected in patients allocated to the "active" compound (intervention) arm as compared to those assigned to a placebo.

详细描述

Adenomatous polyps (or adenoma) are benign lesions of the large bowel that are frequent in people aged 60 or more: about one in four of them has at least one adenoma. In time, adenoma could progress to cancer. Even though only a small rate of adenomas will develop into cancer almost 70-80% of colorectal cancer origin from an adenoma and colorectal cancer is one of the most frequent malignant tumors in the western world. Several epidemiological studies showed that subjects who had low intake and/or low blood levels of selenium were at increased risk of developing colorectal cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 25-75 years
  • at least one histologically confirmed adenoma endoscopically removed from the large bowel resulting in a polyp-free colon-rectum (clean colon).

排除标准

  • polypectomy performed more than 6 months before enrolment in the trial
  • history of Familial Adenomatous Polyposis
  • inflammatory bowel disease
  • adenoma with invasive carcinoma
  • ten or more adenomas
  • large sessile adenoma (3 cm or more
  • colorectal resection
  • invasive cancer at any site
  • life-threatening and/or chronic heart, liver or kidney diseases
  • current use of vitamin or calcium supplements
  • mental disability

研究组 & 干预措施

antioxidants

Experimental

tablets composed of 200 mcg selenium [as l-selenomethionine], 30 mg zinc, 2 mg vitamin A [retinol], 180 mg vitamin C [ascorbic acid] and 30 mg vitamin E [D-α-tocopherol acetate]

干预措施: antioxidants (Drug)

Sugar pill

Placebo Comparator

placebo had an identical appearance as intervention

干预措施: placebo (Drug)

结局指标

主要结局

occurrence of metachronous adenomas or cancer detected during endoscopic follow up examinations

时间窗: five years

次要结局

未报告次要终点

研究者

发起方
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
申办方类型
Other
责任方
Principal Investigator
主要研究者

Luigina Bonelli

MD, responsible of the unit of secondary prevention and screening

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

研究点 (1)

Loading locations...

相似试验

Antioxidant Supplement and Reduction of Metachronous... | 临床试验